Table 1.
General characteristics of microarray and RNA-sequencing datasets on ovarian carcinoma.
| Study | Test method/platform | Country | Year | OVCA group | Noncancerous ovary controls |
|---|---|---|---|---|---|
| GSE105437 | GPL570 | South Korea | 2017 | 10 | 5 |
| GSE29450 | GPL570 | USA | 2011 | 10 | 10 |
| GSE18520 | GPL570 | USA | 2009 | 53 | 10 |
| GSE10971 | GPL570 | Canada | 2008 | 13 | 24 |
| GSE54388 | GPL570 | USA | 2017 | 16 | 6 |
| GSE14407 | GPL570 | USA | 2009 | 12 | 12 |
| GSE36668 | GPL570 | Norway | 2012 | 4 | 4 |
| GSE119054 | GPL19615 | China | 2019 | 6 | 3 |
| GSE66957 | GPL15048 | USA | 2015 | 57 | 12 |
| GSE146553 | GPL6244 | USA | 2020 | 46 | 9 |
| GSE124766 | GPL6480 | Germany | 2020 | 20 | 8 |
| GSE132289 | GPL20301 | UK | 2020 | 5 | 3 |
| GSE155310 | GPL18573 | UK | 2020 | 21 | 6 |
| TCGA_GTEx_ovary | RNA-seq | USA | 2021 | 379 | 88 |
OVCA: ovarian carcinoma.